Paul F. Bray

13.0k total citations · 1 hit paper
175 papers, 8.8k citations indexed

About

Paul F. Bray is a scholar working on Hematology, Cardiology and Cardiovascular Medicine and Molecular Biology. According to data from OpenAlex, Paul F. Bray has authored 175 papers receiving a total of 8.8k indexed citations (citations by other indexed papers that have themselves been cited), including 105 papers in Hematology, 47 papers in Cardiology and Cardiovascular Medicine and 37 papers in Molecular Biology. Recurrent topics in Paul F. Bray's work include Platelet Disorders and Treatments (97 papers), Antiplatelet Therapy and Cardiovascular Diseases (41 papers) and Cell Adhesion Molecules Research (34 papers). Paul F. Bray is often cited by papers focused on Platelet Disorders and Treatments (97 papers), Antiplatelet Therapy and Cardiovascular Diseases (41 papers) and Cell Adhesion Molecules Research (34 papers). Paul F. Bray collaborates with scholars based in United States, France and Australia. Paul F. Bray's co-authors include Pascal J. Goldschmidt‐Clermont, Leonard C. Edelstein, Nauder Faraday, Lewis C. Becker, Thomas S. Kickler, K. Vinod Vijayan, Chad A. Shaw, Srikanth Nagalla, Owen J. T. McCarty and Shaker A. Mousa and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and JAMA.

In The Last Decade

Paul F. Bray

171 papers receiving 8.6k citations

Hit Papers

A Polymorphism of a Platelet Glycoprotein Receptor as an ... 1996 2026 2006 2016 1996 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Paul F. Bray United States 53 3.3k 2.9k 2.0k 1.3k 1.1k 175 8.8k
Hans Deckmyn Belgium 55 4.3k 1.3× 2.1k 0.7× 1.9k 1.0× 1.4k 1.1× 275 0.2× 291 9.8k
Steven R. Lentz United States 60 3.0k 0.9× 1.5k 0.5× 2.3k 1.2× 1.6k 1.3× 377 0.3× 199 10.6k
Andrew L. Frelinger United States 50 3.2k 1.0× 4.0k 1.4× 1.3k 0.7× 2.1k 1.6× 594 0.5× 170 9.0k
Björn Wiman Sweden 36 2.7k 0.8× 1.5k 0.5× 1.4k 0.7× 1.1k 0.9× 1.0k 0.9× 92 8.0k
François Lanza France 51 3.9k 1.2× 1.3k 0.5× 1.5k 0.8× 1.2k 1.0× 172 0.2× 195 7.1k
David‐Alexandre Trégouët France 45 1.3k 0.4× 1.2k 0.4× 1.9k 1.0× 685 0.5× 420 0.4× 189 6.8k
Xiaoping Du United States 50 3.4k 1.0× 1.4k 0.5× 2.3k 1.2× 841 0.7× 192 0.2× 104 7.2k
Wolfgang Bergmeier United States 47 3.4k 1.1× 1.4k 0.5× 1.5k 0.8× 827 0.6× 168 0.1× 139 6.8k
Aaron J. Marcus United States 50 1.6k 0.5× 1.5k 0.5× 1.8k 0.9× 930 0.7× 459 0.4× 128 7.6k
Gerald J. Roth United States 35 2.3k 0.7× 1.9k 0.6× 1.9k 1.0× 1.1k 0.8× 154 0.1× 82 8.0k

Countries citing papers authored by Paul F. Bray

Since Specialization
Citations

This map shows the geographic impact of Paul F. Bray's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul F. Bray with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul F. Bray more than expected).

Fields of papers citing papers by Paul F. Bray

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paul F. Bray. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul F. Bray. The network helps show where Paul F. Bray may publish in the future.

Co-authorship network of co-authors of Paul F. Bray

This figure shows the co-authorship network connecting the top 25 collaborators of Paul F. Bray. A scholar is included among the top collaborators of Paul F. Bray based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paul F. Bray. Paul F. Bray is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Denorme, Frederik, Nicole D. Armstrong, Marshall L. Stoller, et al.. (2023). OC 03.4 A Common, Racially Diverse Protease Activated Receptor 4 Functional Variant Impacts Ischemic Stroke Outcomes: Evidence for a Pharmacogenetic Effect. Research and Practice in Thrombosis and Haemostasis. 7. 100312–100312. 1 indexed citations
2.
Manne, Bhanu Kanth, Robert A. Campbell, Seema Bhatlekar, et al.. (2022). MAPK-interacting kinase 1 regulates platelet production, activation, and thrombosis. Blood. 140(23). 2477–2489. 16 indexed citations
3.
Montenont, Emilie, Seema Bhatlekar, Shancy Jacob, et al.. (2021). CRISPR-edited megakaryocytes for rapid screening of platelet gene functions. Blood Advances. 5(9). 2362–2374. 11 indexed citations
4.
Ross, Justyne, Bing Zhang, Kristy Lee, et al.. (2021). Specifications of the variant curation guidelines for ITGA2B/ITGB3: ClinGen Platelet Disorder Variant Curation Panel. Blood Advances. 5(2). 414–431. 22 indexed citations
5.
Basak, Indranil, Frederik Denorme, Jesse W. Rowley, et al.. (2021). Neutrophil cathepsin G proteolysis of protease-activated receptor 4 generates a novel, functional tethered ligand. Blood Advances. 6(7). 2303–2308. 13 indexed citations
6.
Rondina, Matthew T., Deepak Voora, Lukas M. Simon, et al.. (2019). Longitudinal RNA-Seq Analysis of the Repeatability of Gene Expression and Splicing in Human Platelets Identifies a Platelet SELP Splice QTL. Circulation Research. 126(4). 501–516. 37 indexed citations
7.
Henke, David, Andrew R. Ghazi, Marvin T. Nieman, et al.. (2018). The protease‐activated receptor 4 Ala120Thr variant alters platelet responsiveness to low‐dose thrombin and protease‐activated receptor 4 desensitization, and is blocked by non‐competitive P2Y12 inhibition. Journal of Thrombosis and Haemostasis. 16(12). 2501–2514. 20 indexed citations
8.
Bray, Paul F., Doyle M. Cummings, Susan L. Morrissey, et al.. (2013). Improved Outcomes in Diabetes Care for Rural African Americans. The Annals of Family Medicine. 11(2). 145–150. 30 indexed citations
9.
Stolla, Moritz, Jaroslav Pelisek, Marie-Luise von Brühl, et al.. (2012). Fractalkine Is Expressed in Early and Advanced Atherosclerotic Lesions and Supports Monocyte Recruitment via CX3CR1. PLoS ONE. 7(8). e43572–e43572. 49 indexed citations
10.
Hong, Wei, Altaf A. Kondkar, Srikanth Nagalla, et al.. (2011). Transfection of Human Platelets with Short Interfering RNA. Clinical and Translational Science. 4(3). 180–182. 20 indexed citations
11.
Feldman, Arthur M., Thomas Force, David J. Whellan, et al.. (2010). Commentary: Advancing the Research Mission in an Academic Department: The Creation of a Center for Translational Medicine. Clinical and Translational Science. 3(4). 178–181. 2 indexed citations
12.
Kondkar, Altaf A., Molly S. Bray, Suzanne M. Leal, et al.. (2009). VAMP8/endobrevin is overexpressed in hyperreactive human platelets: suggested role for platelet microRNA. Journal of Thrombosis and Haemostasis. 8(2). 369–378. 156 indexed citations
13.
Bray, Paul F., Timothy D. Howard, Eric Vittinghoff, David C. Sane, & David M. Herrington. (2006). Effect of genetic variations in platelet glycoproteins Ibα and VI on the risk for coronary heart disease events in postmenopausal women taking hormone therapy. Blood. 109(5). 1862–1869. 33 indexed citations
14.
Cooke, Glen E., Amy K. Ferketich, Melvin L. Moeschberger, et al.. (2006). Effect of Platelet Antigen Polymorphism on Platelet Inhibition by Aspirin, Clopidogrel, or Their Combination. Journal of the American College of Cardiology. 47(3). 541–546. 64 indexed citations
15.
Leng, Xing-Hong, Wei Zhang, Bernhard Nieswandt, & Paul F. Bray. (2005). Effects of Estrogen Replacement Therapies on Mouse Platelet Function and Glycoprotein VI Levels. Circulation Research. 97(5). 415–417. 20 indexed citations
16.
Bergeron, Angela L., et al.. (2003). Duration of exposure to high fluid shear stress is critical in shear-induced platelet activation-aggregation. Thrombosis and Haemostasis. 90(10). 672–678. 47 indexed citations
17.
Yee, Donald L., Jennifer R. Wood, Angela L. Bergeron, et al.. (2003). Thr-145 and VNTR C/D polymorphisms on glycoprotein Ibalpha demonstrate increased platelet reactivity to shear stress and ristocetin. Blood. 102(11). 78316. 1 indexed citations
18.
Jin, Ying, Hal Dietz, Robert A. Montgomery, et al.. (1996). Glanzmann thrombasthenia. Cooperation between sequence variants in cis during splice site selection.. Journal of Clinical Investigation. 98(8). 1745–1754. 52 indexed citations
19.
Morozov, Victor N., et al.. (1991). Survey of small molecule and ion binding to beta 2-microglobulin--possible relation to BEN.. PubMed. 34. S85–8. 4 indexed citations
20.
Bray, Paul F., Jean‐Philippe Rosa, Geoffrey I. Johnston, et al.. (1987). Platelet glycoprotein IIb. Chromosomal localization and tissue expression.. Journal of Clinical Investigation. 80(6). 1812–1817. 70 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026